In March of 2009, Institutional Pharmacy Technology marketing leader, Todd S. Eury, launched the Pharmacy Podcast Show. Over the years, the Pharmacy Podcast has accumulated over 67,000+ listeners and subscribers and is the most popular and downloaded podcast about the Pharmacy Industry. The Pharmacy…
Listeners of Pharmacy Podcast Network that love the show mention: pharmacy podcast, ppn, student pharmacists, pharmacy students, podcast network, todd's, reform, pulse, healthcare, profession, nathan, careers, independent, patient, traditional, timely, medical, generally, platform, opportunity.
The Pharmacy Podcast Network is an incredibly informative and diverse podcast that covers a wide range of topics related to the pharmacy profession. Hosted by Todd Eury, this podcast features interviews with industry leaders, discussions on healthcare issues, and innovative ideas within the field. The network brings together pharmacists, technicians, and other healthcare professionals to provide valuable insights into the ever-changing landscape of pharmacy.
One of the best aspects of The Pharmacy Podcast Network is its ability to engage listeners through relevant and educational content. The guests that Todd brings on are knowledgeable and experienced in their respective fields, providing unique perspectives on various topics. From discussions about career advancement to updates on industry trends, this podcast offers valuable information that can benefit any listener working in pharmacy or healthcare.
Additionally, The Pharmacy Podcast Network stands out for its commitment to supporting independent pharmacies. With a focus on promoting the profession and empowering pharmacists to make a difference in their communities, it serves as a valuable resource for those looking for practical tips and strategies for success. By featuring leaders in the industry who have forged their own paths and created innovative practices, this podcast inspires listeners to think outside the box and explore new opportunities within their careers.
While there are many excellent aspects of The Pharmacy Podcast Network, one potential drawback is that some episodes may not be as relevant or interesting to all listeners. Due to the broad range of topics covered, there may be episodes that are more niche or specific to certain areas of pharmacy practice. However, with such a vast library of content available, there is still plenty for every listener to enjoy and learn from.
In conclusion, The Pharmacy Podcast Network is an invaluable resource for anyone in the pharmacy profession or interested in healthcare. With its diverse range of topics, knowledgeable guests, and dedication to promoting innovation and success within the field, this podcast provides an engaging platform for learning and growth. Whether you're looking for career advice or want to stay up-to-date with the latest industry news, The Pharmacy Podcast Network is a must-listen for pharmacy professionals.

In this edition of Essential, we look at how we're pushing back against the FDA's upcoming ban on desiccated thyroid extract, why drugmakers' latest tactics against compounding pharmacies are backfiring, and we give you a great way to make sure your practice is performing at its best. Then we take a deep dive with attorney and pharmacist Mark Boesen into the lawsuits being filed against compounding pharmacies, what the results have been, and how they might affect more than just pharmacy in the future. Boesen & Snow Law: https://www.boesensnowlaw.com/ DTE story (https://a4pc.org/news/ask-your-patients-help-us-protect-dte-access) “FDA's confusing warning letters” (https://a4pc.org/news/fdas-confusing-warning-letters) “FDA's green list: Not our problem?” (https://a4pc.org/news/fdas-green-list-not-our-problem) Compounding.com/thyroid Best practices documents (a4pc.org/bestpractices) National Review article on FDA crackdown (https://archive.ph/LYy7t)

NSAIDs are everywhere, prescription, OTC, topical, oral, injectable, you name it! In an era of Opioidphobia, are they really a panacea? Heck no, all medications come with baggage. We could spend hours talking about NSAIDs, and not even get to the elephant in the room: Which NSAID for Which Patient? So we'll go there in this succinct, yet comprehensive rapid review of all things NSAIDs on the Pain Pod! Come one, come all, to the Pain Pod!!! Pain Guy • www.painguy.us

In this episode of The Pediatric Pharmacist Review, we delve into the 2025 KIDs List—the Pediatric Pharmacy Association's updated guide highlighting key potentially inappropriate medications in pediatric care. This comprehensive list serves as a critical resource for clinicians aiming to enhance medication safety and optimize pharmacotherapy in pediatric populations. Meet the Experts: Dr. Rachel S. Meyers brings a wealth of experience as a Clinical Professor at Rutgers University and a Pediatric Clinical Pharmacist at Cooperman Barnabas Medical Center. Her clinical insights and academic contributions have significantly influenced pediatric pharmacy practice. Dr. David Hoff serves as the Pharmacy Director for Acute Care at Children's Minnesota and holds the position of Section Editor at JPPT. With over 30 years of experience, he has been instrumental in developing and updating the KIDs List, ensuring it reflects the latest evidence and best practices. Key Discussion Points: The evolution and significance of the KIDs List in pediatric pharmacotherapy Strategies for integrating the KIDs List into clinical practice The impact of inappropriate medications on pediatric patient outcomes Collaborative efforts in pediatric medication safety Further Reading: For a comprehensive understanding, access the full 2025 KIDs List here: 2025 KIDs List PDF

The Pharmacy Podcast Network is back on the show floor at the NASP Annual Expo, live in Denver, CO! Thank you JB Consulting for Sponsoring this episode! On part one of this series we interview: Jennifer Noonan with Accessia Health Shaun Jensen with JB Consulting Kevin Kallmes with Nested Knowledge AI Lee Pratt with ProChant Mai Tang with Two Trees Consulting Nick Calla with Orsini Reed Kalna with Kaiser Permanente Richard Brook with Better Worldwide Health Ryan Clarke with Keysource Sheila Arquette, President and CEO of the NASP

Access, Advocacy & Appreciation: The Heart of Pharmacy in Motion --it's time to #TWIRx on October 24th, 2025, it's FRIDAY!! Up first is TWIRx News: From Pharmacy Times, Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy. https://lnkd.in/e2CwGUt8 NEXT from Drug Store News, Pharmacies can close health care gaps for millions while realizing substantial savings for employers A new national study from the Health Action Alliance, commissioned by NACDS, shows pharmacy-based care reduces costs while meeting employee demands for convenient access. https://lnkd.in/eYmrQnHQ NEXT from Open PR, New Research Peptide Supplier Plans Pharmacy Collaborations to Support Licensed Wellness Clinic Sector https://lnkd.in/evkgZtn5 NEXT Study shows alarming drop in pharmacy access in Massachusetts --reporting from WWLP-22News from Boston https://lnkd.in/egWg6G3r In this episode of This Week in Pharmacy, host Todd Eury welcomes featured guest Tiara Green, President of Accessia Health, whose mission is to connect patients without insurance to life-saving medication funding. LINK: https://lnkd.in/gV4VjeZn We also check in with Jesse McCullough for Day 24 of the 31-Day #Pharmacist Month Challenge, with a special call to action to support the 40+ shows and incredible hosts creating content for the pharmacy profession through the Pharmacy Podcast Network. LINK: https://lnkd.in/efvZ6Smv Plus, Mike Johnston, CPhT-Adv, CEO of the NPTA - National Pharmacy Technician Association (NPTA), joins us to share insights on Meaningful Recognition and what pharmacy technicians truly want as we celebrate World Pharmacy Technician Day. LINK: https://lnkd.in/gz-Gcxvg

In the final installment of our three-part series, host Todd Eury wraps up his live coverage from the 2025 FrameworkLTC Innovation Conference. Tune in for more engaging interviews with LTC pharmacy attendees, partner exhibitors, and SoftWriters team members as they reflect on the event's biggest moments and discuss what's ahead for the LTC pharmacy community.

The Pharmacy Podcast Network is back on the show floor at the NASP Annual Expo, live in Denver, CO! Thank you Accessia for Sponsoring this episode! On part two of this series we interview: Jennifer Noonan with Accessia Health Nick Negri with ALTOR Cecila Byers with Surescripts Jill Paslier with Specia Jon Hamrick with Curatio Advisors Jonathan Orgurchak and Brandon Hardin Steve Pharmacy Attorney Tammy Dean with Cold Chain Technologies

The NCPA Digest, presented by the National Community Pharmacists Association (NCPA) and Cardinal Health, is a comprehensive analysis quantifying and profiling the state of independent community pharmacy. From benchmarking performance and implementing process improvements to identifying new strategies that have proven successful for their peers, there are many ways independent pharmacies can leverage this annual report. In this episode, NCPA's Doug Hoey and Lisa Schwartz join Cardinal Health's Michelle Britt and Rebecca McGrath to discuss the findings from the 2025 NCPA Digest and how independent pharmacists' collective voices help inform this industry publication. They also share examples of how readers can use the Digest as an advocacy tool in conversations with elected officials and policymakers.

PRISM Enters the Chat & LTC Insurance in Pharmacy | TWIRx RxRated Version

The Pharmacy Podcast Network is back on the show floor at the NASP Annual Expo, live in Denver, CO! Thank you JB Consulting for Sponsoring this episode! On part one of this series we interview: Christine Tang Wilson with Lumicera Health Services Amanda Awe with VLP Christopher Corsi, CEO, CassianRx Hayley Burgess with Inovalon Eric Robertson with DoseSpot Harry Travis with The Travis Group LLC Ethan Wynn with Sphinx Strategies Heidi Polleck with Outcomes

In part two of our exclusive three-part series, host Todd Eury continues the conversation live from the 2025 FrameworkLTC Innovation Conference. Hear from LTC pharmacy professionals, trusted partners, and SoftWriters experts as they share their experiences, key takeaways, and perspectives on the evolving world of long-term care pharmacy.

I had the honor of interviewing a like-hearted soul whom I deeply respect and admire, around the topic of transmuting our grief, rage + fear about the wider big picture of the world. For such a heavy topic, I came out of it inspired to connect deeper with nature, and grateful for the gift of life. Gwyneth Jones guides individuals through the emotional and spiritual journey of confronting the state of our world, drawing upon a diverse toolkit that includes ecotherapy, emotional intelligence, mindfulness, and positive psychology. She is a certified coach and Work that Reconnects facilitator, as well as a writer and podcast host on topics relating to our psychological and spiritual response to collapse, ecopsychology and our connection to the web of life, and effective changemaking. Connect with Gwyneth via: Email: gwynethajones86@gmail.com Website: Gwyneth Jones Coach & Connector FB: Gwyneth Jones - Coach & Connector IG: @gwynethjones.connectioncoach Linked In: Gwyneth Jones Get the epic “Staying Grounded in Times of Crisis” ebook, available as a free download from her website. And check out our upcoming livestream about herbalism as a form of resilience on September 25th, and our interactive workshop on this topic on October 23rd! We look forward to building community and sharing the tools that our ancestors worked with and are still relevant today. Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com. Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

Join us as we celebrate 10 years of biosimilars. In this episode of The Counter Talk™ Podcast host Jason Callori speaks with Dracey Poore, Director of Biosimilars at Cardinal Health to discuss the evolution of biosimilars and their impact on the healthcare landscape. Dracey shares valuable information on its importance within the market and role of pharmacists. Click here to download the report and learn more. Links: Apple Music – https://podcasts.apple.com/us/podcast/10-years-of-biosimilars-a-decade-of-progess/id1616706265?i=1000712269701 Spotify – https://open.spotify.com/episode/16rgiAVRqq2gqQBrXk1nDp Cardinal Health - https://www.cardinalhealth.com/en/services/retail-pharmacy/resources-for-pharmaceutical-distribution/independent-pharmacy-podcast

The host has been a community pharmacy advocate for 22 years. Always looking for ways to help community pharmacies be more profitable. The guest is an experienced Pharmacist with a demonstrated history of working in the pharmaceutical industry. Skilled in Diabetes, Pharmacy Practice, Community Pharmacy, and Clinical Pharmacology.

This podcast is sponsored by YARAL Pharma. In this episode, we are focusing on the management of hypothyroidism -- a treatable, but not curable condition – and will explore unique challenges for patients with hypothyroidism in long-term care – from tolerability and formulation considerations to consistent dosing and patient needs. Dr. Tamara Ruggles is not affiliated with YARAL Pharma. All views and opinions regarding hypothyroidism are solely her own and are not attributable to YARAL or the Pharmacy Podcast Network. IMPORTANT SAFETY INFORMATION for levothyroxine sodium capsules INDICATION AND USAGE Levothyroxine sodium capsules are L-thyroxine (T4) indicated for adults and pediatric patients 6 years and older with: Hypothyroidism - As replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression - As an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well differentiated thyroid cancer Limitations of Use: Levothyroxine sodium capsules are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with Levothyroxine sodium capsules may induce hyperthyroidism. Levothyroxine sodium capsules are not indicated for treatment of transient hypothyroidism during the recovery phase of subacute thyroiditis WARNING: NOT FOR THE TREATMENT OF OBESITY OR FOR WEIGHT LOSS Thyroid hormones, including levothyroxine sodium capsules, either alone or with other therapeutic agents, should not be used for the treatment of obesity or for weight loss. In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic effects. Contraindications Uncorrected adrenal insufficiency Warnings and Precautions Cardiac adverse reactions in the elderly and in patients with underlying cardiovascular disease: Initiate Levothyroxine sodium capsules at less than the full replacement dose because of the increased risk of cardiac adverse reactions, including atrial fibrillation Myxedema coma: Do not use oral thyroid hormone drug products to treat myxedema coma Acute adrenal crisis in patients with concomitant adrenal insufficiency: Treat with replacement glucocorticoids prior to initiation of levothyroxine sodium capsules treatment Prevention of hyperthyroidism or incomplete treatment of hypothyroidism: Proper dose titration and careful monitoring is critical to prevent the persistence of hypothyroidism or the development of hyperthyroidism Worsening of diabetic control: Therapy in patients with diabetes mellitus may worsen glycemic control and result in increased antidiabetic agent or insulin requirements. Carefully monitor glycemic control after starting, changing, or discontinuing thyroid hormone therapy Decreased bone mineral density associated with thyroid hormone over-replacement: Over-replacement can increase bone reabsorption and decrease bone mineral density. Give the lowest effective dose Adverse Reactions Common adverse reactions with levothyroxine therapy are primarily those of hyperthyroidism due to therapeutic overdosage. They include the following: General: fatigue, increased appetite, weight loss, heat intolerance, fever, excessive sweating Central Nervous System: headache, hyperactivity, nervousness, anxiety, irritability, emotional ability, insomnia Musculoskeletal: tremors, muscle weakness Cardiovascular: palpitations, tachycardia, arrythmias, increased pulse and blood pressure, heart failure, angina, myocardial infarction, cardiac arrest Respiratory: dyspnea Gastrointestinal (GI): diarrhea, vomiting, abdominal cramps, elevations in liver function tests Dermatologic: hair loss, flushing Endocrine: decreased bone mineral density Reproductive: menstrual irregularities, impaired fertility Adverse Reactions in Children Pseudotumor cerebri and slipped capital femoral epiphysis have been reported in children receiving levothyroxine therapy. Overtreatment may result in craniosynostosis in infants and premature closure of the epiphyses in children with resultant compromised adult height. Seizures have been reported rarely with the institution of levothyroxine therapy. Hypersensitivity Reactions Hypersensitivity reactions to inactive ingredients (in this product or other levothyroxine products) have occurred in patients treated with thyroid hormone products. These include urticaria, pruritis, skin rash, flushing, angioedema, various GI symptoms (abdominal pain, nausea, vomiting and diarrhea), fever, arthralgia, serum sickness and wheezing. Hypersensitivity to levothyroxine itself is not known to occur. Drug Interactions: Many drugs and some foods can exert effects on thyroid hormone pharmacokinetics (e.g., absorption, synthesis, secretion, catabolism, protein binding, and target tissue response) and may alter the therapeutic response to Levothyroxine sodium capsules. Administer at least 4 hours before or after drugs that are known to interfere with absorption. See full prescribing information for drugs that affect thyroid hormone pharmacokinetics and metabolism. To report SUSPECTED ADVERSE REACTIONS, contact Yaral Pharma Inc. at 1-866-218-9009, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. For Full Prescribing Information, including Boxed Warning, go to www.yaralpharma.com/levothyroxine-pi.

In part one of our special three-part series, join host Todd Eury as he takes you inside the 2025 FrameworkLTC Innovation Conference. Recorded live on-site, this episode features conversations with long-term care (LTC) pharmacy leaders, partner exhibitors, and members of the SoftWriters team. Hear firsthand insights and success stories that highlight innovation, collaboration, and the future of LTC pharmacy.

Hyperthyroidism, though less common than hypothyroidism in elderly populations, poses unique challenges in long-term care (LTC) settings. In older adults, symptoms can be subtle or atypical—manifesting as unexplained weight loss, anxiety, atrial fibrillation, or cognitive decline, which may be mistaken for normal aging or other chronic conditions. In LTC facilities, where polypharmacy and comorbidities are prevalent, the role of the pharmacist consultant is critical in identifying potential signs of hyperthyroidism, reviewing lab results, and ensuring appropriate medication management. While levothyroxine is a standard therapy for hypothyroidism, its use in LTC requires close monitoring, especially to avoid overtreatment that can mimic or induce hyperthyroid symptoms. Pharmacist consultants play a key role in evaluating levothyroxine dosing—considering factors like renal function, drug interactions (e.g., calcium, iron supplements), and changes in patient weight or dietary habits. In cases where hyperthyroidism is present or suspected, pharmacists assist in monitoring antithyroid medications such as methimazole or managing transitions after radioactive iodine therapy or surgery. Their involvement ensures thyroid function is properly assessed, doses are adjusted appropriately, and adverse events—like fractures or cardiovascular risks from overtreatment—are minimized.

REFERENCES 1. Miller RV. Tylenol autism lawsuit. Lawsuit Information Center. September 21, 2025. Accessed September 25, 2025. https://www.lawsuit-information-center.com/tylenol-autism-lawsuit.html 2. Gerstein AS, Niederhelman EF. Harvard's public health dean was paid $150,000 to testify Tylenol causes autism. The Harvard Crimson. September 24, 2025. Accessed September 25, 2025. https://www.thecrimson.com/article/2025/9/24/autism-dean-public-health/ 3. Poll: Most Americans encounter health misinformation, and most aren't sure whether it's true or false. News Release. KFF. August 22, 2023. Accessed September 26, 2025. https://www.kff.org/covid-19/poll-most-americans-encounter-health-misinformation-and-most-arent-sure-whether-its-true-or-false/ 4. Prada D, Ritz B, Bauer AZ, et al. Evaluation of the evidence on acetaminophen use and neurodevelopmental disorders using the Navigation Guide methodology. Environ Health. 2025 Aug 14;24(1):56. doi: 10.1186/s12940-025-01208-0. 5. Ahlqvist VH, Sjöqvist H, Dalman C, et al. Acetaminophen use during pregnancy and children's risk of autism, ADHD, and intellectual disability. JAMA. 2024;331(14):1205–1214. doi:10.1001/jama.2024.3172 6. Alemany S, Avella-García C, Liew Z, et al. Prenatal and postnatal exposure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: meta-analysis in six European population-based cohorts. Eur J Epidemiol. 2021 Oct;36(10):993-1004. doi: 10.1007/s10654-021-00754-4. 7. Ji Y, Azuine RE, Zhang Y, et al. Association of cord plasma biomarkers of in utero acetaminophen exposure with risk of attention-deficit/hyperactivity disorder and autism spectrum disorder in childhood. JAMA Psychiatry. 2020;77(2):180–189. doi:10.1001/jamapsychiatry.2019.3259

Celebrating the Launch of American Pharmacists Month 2025 “Caring for our Communities” This Week in Pharmacy (TWIRx) Friday, October 3, 2025 Episode Overview Today marks the kickoff of American Pharmacists Month 2025, a time to recognize the essential role pharmacists play across all healthcare settings. This special TWIRx episode spotlights leaders and innovators shaping pharmacy practice, technology, and patient care — and challenges the profession to embrace a 31-day journey of advocacy, community connection, and transformation. TWIRx NEWS Former Rep. Tiahrt: Pharmacy Benefit Manager bill could shut down CVS in Kansas | Opinion Read more at: https://www.kansas.com/opinion/guest-commentary/article312355904.html#storylink=cpy Neronha lawsuit against CVS Caremark can help save my Middletown pharmacy: Guest View https://www.newportri.com/story/opinion/columns/guest/2025/10/03/neronha-lawsuit-against-cvs-can-help-save-middletown-pharmacy-guest-view/86471928007/ FDA Approves Lurbinectedin Combination Regimen in Extensive-Stage SCLC https://www.pharmacytimes.com/view/fda-approves-lurbinectedin-combination-regimen-in-extensive-stage-sclc Building an Opioid Stewardship Program in Cancer Care: Pharmacist Roles, Challenges, and Patient Safety https://www.pharmacytimes.com/view/building-an-opioid-stewardship-program-in-cancer-care-pharmacist-roles-challenges-and-patient-safety Featured Guests Dr. Jesse McCullough, PharmD Founder, Keystone Pharmacy Insights Introducing the American Pharmacists Month 31-Day Challenge, a call to action for pharmacists to engage, educate, and elevate their communities. Bil Schmidtknecht Patient Protector Sharing insights on patient advocacy, protecting access to care, and the pharmacist's role in navigating today's healthcare complexities. Dr. Devin Bustin, MD Chief Medical Officer, OvaryIt Dr. Lissette Logan, PharmD COO, OvaryIt Together, Dr. Bustin and Dr. Logan discuss innovative pharmacist-driven care models, treatment tracking, and platforms like PRISM designed to ensure pharmacists are recognized — and reimbursed — for their expertise. Dr. Jill Kolesar, PharmD Dean, College of Pharmacy, The University of Iowa Highlighting the future of pharmacy education and how academia is preparing the next generation for expanded clinical and community roles. Dr. Jason Lang, PharmD Wellgistics Exploring the logistics and supply chain innovations that keep pharmacies agile in serving patient needs, especially as new therapies and technologies emerge. WELLGISTICS News: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/wellgistics-health-nasdaq-wgrx-and-theracosbio-partner-to-expand-nati-1079815 SUBSCRIBE TO TWIRx HERE: https://open.spotify.com/show/52NZjr9asE8fLrrbsMvBlQ Celebrating the Launch of American Pharmacists Month 2025 | TWIRx

Tune in to a multi-episode recap of the Retail Business Conference with returning special guest host Adam Robinson, Owner of Save-Rite Drugs in Lexington, Kentucky. Receive the highlights from Cardinal Health customers, employees, services and more at RBC 2025. The final episode's topic is on the importance of celebrating women in pharmacy, elevating your leadership skills, differentiating in the community and overcoming challenges.

In this episode, Tamara sits down with Carrie Krebs, PharmD, to talk about the important role pharmacists play in hospice care. Together, they cover commonly used medications, key regulations, deciding when to stop certain drugs, and more. Carrie also opens up with a personal story about her own loved one's hospice journey.

Financial pressures, reimbursement challenges, and adapting to new regulations Brian reflects on his transition from VP at Bi-Mart to owner of Caris Pharmacy, sharing insights on managing margins, operations, and strategy Spotlight on Indiana's Disclosure of Actual Acquisition Cost (Indiana Code § 27-1-24.2) effective Jan 1, 2026, and what it means for independents and regional chains alike

This episode dives into the future of pharmacy through the lens of pharmacogenomics (PGx). Dr. Melissa Smith speaks with Dr. Vanessa Lesneski about the steep decline in pharmacy school enrollment and how PGx could reignite interest in the profession. They explore how PGx has rapidly evolved from an elective to a core component of pharmacy education, the rise of certification and training pathways, and the expanding career opportunities in diverse care settings. The discussion also tackles critical questions around pharmacists' role in test interpretation, skepticism about PGx adoption, and what it will take for the field to move from niche to mainstream.

On "This Week in Pharmacy" for September 26th, we're talking about Trust in Healthcare, World Pharmacists Day, and Cell & Gene Therapy. Today's co-host is Dr. Melissa Smith, PharmD CPH with Florida PGx Consulting LLC. https://www.floridapgxconsulting.com/ First, #TWIRx News - the FDA approves Inluriyo imlunestrant on 9/25/2025 which is to treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, estrogen receptor-1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. (https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2025) Second, Nested-Knowledge - is going to revolutionize information access and leverage. This is a powerful tool with evidence synthesis tools for medical researchers. This will help accelerate, collaborate, automate and share the latest and personalized treatment plans. (https://nested-knowledge.com/) Next, announcing "Evidence based Podcasting", the new standard in audio learning for Providers and next level in podcast Continuing Medical Education (CME). (https://pharmacypodcast.com/2025/09/26/evidence-based-podcasting-and-the-future-of-medical-education/ ) Shout out to Nick Calla with Orsini, a leader in rare disease pharmacy solutions, has been chosen by Crinetics Pharmaceuticals, Inc., as a specialty pharmacy partner for PALSONIFY™ (paltusotine), a nonpeptide, selectively-targeted somatostatin receptor type 2 nonpeptide (SST2) agonist. (https://www.wvnews.com/news/around_the_web/partners/pr_newswire/subject/licensing_marketing_agreements/orsini-selected-as-specialty-pharmacy-partner-for-crinetics-palsonify-paltusotine/article_9b42bfe7-69a6-58be-98ff-5e2245145415.html) Today we have two guest Pharmacists to dig into the "Trust in Healthcare" theme of today's #TWIRx -- the godfather of Functional Pharmacy Robert Kress RPh., and Dr. Lauren Castle, PharmD, MS, AFMC - Founder & CEO of Functional Medicine Pharmacists Alliance. Who do you trust? What information is trustworthy and why? Our special feature is updates on 'Cell & Gene Therapy' with McKesson's Head of Cell Gene Advanced Therapies, Joe DePinto at InspiroGene! (https://inspirogene.com/) Today's TWIRx is sponsored by 'Sykes & Company' the Pharmacy Accounting Jedi Masters and Independent Pharmacy Cooperative (IPC) and how they're revolutionzing digital health and new revenues with the iCare+ System! Trust Matters, Cell and Gene, & World Pharmacists Day | TWIRx

Tune in to a multi-episode recap of the Retail Business Conference with returning special guest host Adam Robinson, Owner of Save-Rite Drugs in Lexington, Kentucky. Receive the highlights from Cardinal Health customers, employees, services and more at RBC 2025. Episode Breakdown • Remote Pharmacy Support Services – Learn how independent pharmacies can overcome staffing challenges while lowering costs, generating revenue and improving customer satisfaction through alternate staffing models. • Be the caregiver to your caregiving community - Caregivers face a wide range of challenges, from managing medications and coordinating care to coping with emotional and physical stress. Learn how independent pharmacists can become a vital part of the caregiver support system. • Empowering pharmacists with at-home testing solutions to drive OTC sales - In this episode, we explore the wide range of screening options available and how these tests can drive additional revenue through strategic OTC product recommendations.

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, sits down with Trey Holterman, CEO and Co-Founder of Tennr, a healthcare referral automation platform. They explore Tennr's journey from startup to industry leader and how focused technology speeds patient access, with a look towards what the future holds for patient engagement and care personalization.

NOW, NEW, NEXT: NACDS TSE 2025 in Sunny San Diego was a bustling event filled with information and insights on whats happening NOW, what's NEW, and what comes NEXT! Guests: Andy Crawford - Keysource Lou Ann Myers - Outcomes Crystal Lennartz - President, Health Mart Steven Anderson - CEO, NACDS

Tune in to a multi-episode recap of the Retail Business Conference with returning special guest host Adam Robinson, Owner of Save-Rite Drugs in Lexington, Kentucky. Receive the highlights from Cardinal Health customers, employees, services and more at RBC 2025. On Episode Two, Adam dives into Cardinal Health solutions and services: • Reconciliation (Recon) • Reimbursement Consulting Services (RCS) • Vantus™ HQ Learn how these programs can benefit your independent pharmacy.

This episode of Essential unpacks FDA confusion, California's latest compounding curveball, and pharma-fueled myths about GLP-1s. We spotlight APC's advocacy wins on Capitol Hill and why pharmacy tours pack political punch. Plus, the FDA's eyebrow-raising move to reclassify natural thyroid products — and why it matters for patients everywhere. News item about California reg: https://a4pc.org/news/this-one-little-word-could-trip-you-up Compounding primer: https://join.a4pc.org/hubfs/PDFs/Traditional-Pharmacy-Compounding-101.pdf?hsLang=en APC's guide to hosting a legislator: https://join.a4pc.org/hubfs/PDFs/2021-04_APC-Guidance-Hosting-Pharmacy-Visits.pdf APC in the News: https://a4pc.org/inthenews DTE grassroots campaign: https://compounding.com/thyroid

NOW, NEW, NEXT: NACDS TSE 2025 in Sunny San Diego was a bustling event filled with information and insights on whats happening NOW, what's NEW, and what comes NEXT! Thank you NimbleRx for Sponsoring this episode! Guests: Scott Von Deylen - NimbleRx Chris Cielewich - FLAVORx Sara Roszak - NACDS Brian Hose & Peter Starfas - Epic Pharmacies

It was truly an honor and a great pleasure to talk to a well-respected colleague and friend about his experience as both a pharmacist and an expert in the natural products field. He is a true embodiment of the Myth, Man and Legend. Tune in to learn more about filling in the gaps in the current healthcare climate by utilizing evidence-backed nutraceuticals. Dr. Jeffery A. Johnson, ND, PharmD, RPh, MBA is a dedicated healthcare professional and 30-year combat veteran of the U.S. Armed Forces (USAF). A graduate of Purdue University (BS-Pharm, 1978), he later earned his Doctor of Naturopathy (2000), Doctor of Pharmacy from the University of Kansas (2003), and an MBA. Throughout his career, Dr. Johnson has spent over three decades educating and consulting with healthcare professionals and clients on the integration of nutraceuticals into personal healthcare practices—highlighting both their benefits and potential challenges. Since retiring from active military service in 2017, he has continued his mission of promoting informed, holistic healthcare practices. He currently works part-time as a self-employed Consultant Pharmacist, offering expert guidance on nutraceuticals and overall wellness strategies. Connect with Jeffery via: Email: ntrxpathconsultants@outlook.com Linked In: Dr Jeffery A (Doc Pappy J) Johnson

NOW, NEW, NEXT: NACDS TSE 2025 in Sunny San Diego was a bustling event filled with information and insights on whats happening NOW, what's NEW, and what comes NEXT! Thank you KeySource for Sponsoring this episode! Guests: Andy Crawford - KeySource Arman Ameri - Salvatore Consumer Products Campbell Atkinson - AFT Pharmaceuticals Frank Harvey - CEO Surescripts Ken Thai - 986 Pharmacy Group Lara Loveman - Outcomes Lathe Bigler - First Databank Inc Melinda Su-En Lee - Parcel Health

Inmar Intelligence is a data-driven technology company that provides solutions for retail, healthcare, and supply chain industries. They specialize in optimizing promotions, managing digital couponing, and offering point-of-sale analytics for retailers. In healthcare, they focus on pharmaceutical returns, claims processing, and marketing. In supply chain, they help with inventory management and reverse logistics. Their data analytics platform uses AI to help businesses make smarter decisions, improve efficiency, and drive growth. TailorMed, led by CEO Srulik Dvorsky , is a healthcare technology company that focuses on helping patients manage the financial aspects of their medical care. The platform offers personalized financial assistance, helping patients find and access financial resources like insurance coverage, financial aid programs, and discounts to reduce out-of-pocket medical costs. Here are the key services TailorMed provides: 1. Financial Assistance for Patients: TailorMed helps patients navigate complex healthcare billing by identifying available financial aid, grants, discounts, and programs to reduce treatment costs. 2. Cost Transparency: The platform provides clear information on medical costs, helping patients understand their financial responsibilities and options for managing high healthcare expenses. 3. Technology-Driven Solution: TailorMed uses technology to automate the process of identifying financial resources and integrating these solutions into healthcare providers' systems, making it easier for providers to offer financial help to patients.

Guest Speakers: Ketan Mehta, CEO, PrimeRx David Kirkus, Vice President of MARKET, PrimeRx KEY TAKEAWAYS: PrimeRx is the first pharmacy software to embed a real-time marketplace into dispensing. Pharmacies gain cost control, supply diversification, and workflow efficiency. This innovation comes at a critical time as tariffs and economic pressures escalate.

Join experts in obesity, Robert Kushner, MD, Michael Knight, MD, and Amanda Velazquez, MD, as they discuss impactful communication for patients with obesity. Bob Kushner, MD Amanda Velazquez, MB, DABOM Michael Knight, MD, MSHP, FACP, DABOM

This is a fascinating podcast episode from Dr. Lipid himself on desmosterol. What is it? How do we measure it? Why should we care? Pharmacists are well-positioned to guide patients in understanding the role of desmosterol, how medications may influence its levels, the options for measuring it, and the steps to take if levels are too high or too low. Dr. Thomas Dayspring: linkedin.com/in/thomas-dayspring-md-facp-fnla-3aaa876 or @DrLipid on X Tamara Ruggles, PharmD: linkedin.com/in/tamara-ruggles-491882251 Resource on lipids recommended by Dr. Dayspring: https://familyheart.org/ Wages PA, Kim HH, Korade Z, Porter NA. Identification and characterization of prescription drugs that change levels of 7-dehydrocholesterol and desmosterol. J Lipid Res. 2018 Oct;59(10):1916-1926. doi: 10.1194/jlr.M086991. Epub 2018 Aug 7. PMID: 30087204; PMCID: PMC6168312. Available at: https://pubmed.ncbi.nlm.nih.gov/30087204/ The Geriatric Pharmacy Focus podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions.

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of the National Association of Specialty Pharmacy, sits down with Hillary Gretton, Director of Data Strategy at Claritas Rx. Together, they explore today's challenges in market access and patient journey analytics, and how Access Analytics is helping specialty pharmacies, payers, and partners tackle these barriers. The conversation highlights real-world use cases from Claritas Rx's recent whitepaper, From Prescription to Abandonment: How 31% of Specialty Medications Go Unfilled Across Therapeutic Areas, showing how better data can drive better outcomes.

On 'This Week in Pharmacy' we're talking about the "Fully Powered Event" with Dr. Christina Fontana, we jump into TWIRx News with Andy Crawford from Keysource, preparing for the NASP 2025 in Denver & welcome the Rated Rx Podcast to the PPN! TWIRx News includes: Massachusetts governor orders pharmacies to make COVID shots accessible - from CBS News Hims & Hers stock jumps on Novo Nordisk GLP-1 partnership - from AOL Finance The oldest pharmacy in Texas closes after 153 years - from DeWitt County Today This episode is sponsored by Keysource and Sykes & Company, thank you for supporting the only weekly news podcast in pharmacy, this is TWIRx!!

In this episode, we sit down with the President of the American Medical Association to discuss PBM reform and its impact on patients, physicians, and the future of healthcare. From drug pricing transparency to ensuring access to needed medications, this conversation explores why PBM reform is at the center of today's healthcare policy debates.

In this final part of this three part series we bring you exclusive interviews from the Outcomes booth, recorded on the show floor at ThoughtSpot 2025. Our guests are: Jon Carlson at Outcomes Pharmacist Heidi Polek, Vice President of Product Management at Outcomes Multi-location Pharmacy Owner, and Pharmacy 50 Award winner Dr. Chris Antipas Product Manager at Outcomes, Dalia Rios Paul Shelton Tim Cernohous, Senior Vice President of Community Retail and Long term care Pharmacy at Cencora. This episode is sponsored by Outcomes.

Join our co-hosts Todd Eury and Greg Reybold in this exclusive interview with Conor Sheehey, who most recently served as senior health policy advisor to U.S. Senate Finance Committee Chair Mike Crapo (R-ID). In this role, he advised the Committee on a range of health care policy issues, including prescription drug pricing, telehealth, AI, provider coverage and reimbursement, fraud and abuse, medical devices, and Medicare Parts B and D. Sheehey led several bipartisan legislative efforts, including the development of comprehensive PBM reforms and bipartisan proposals on clinician payment reform and drug shortages.

Psilocybin has demonstrated a long track record of safety and efficacy in a variety of conditions including depression, anxiety, addiction, trauma, and cognitive decline. Although to date, this natural substance remains classified as a Schedule 1 drug, there are protected use scenarios including sincere spiritual use. The Religious Freedom Restoration (RFRA) act lies at the foundation of Setas Seminary's protected use of psilocybin sacrament. With a background in biology, Pam Conboy was trained as a clinical laboratorian and is currently a doctoral student in naturopathic medicine. She is an IIN certified health coach, trained psychedelic facilitator, medical marketing|business development entrepreneur, and ordained minister. With a background in biochemistry and emergency medicine, Leah Linder is a naturopathic physician trained in psychedelic assisted therapy with deep expertise in natural supplement formulation and manufacture. She is a Master Gardener, experienced educator, and ordained minister. Check out the episode and links below for tons of psychedelic learning resources mentioned, and giving a shout out to the Psychedelic Pharmacists Association (PPA) - an excellent first step for fellow pharmacists. Connect with Pam Conboy and Setas Seminary via: Email: pamconboy@setasseminary.org Website: Setas Seminary IG: @setas.seminary Linked In: Pam Conboy Mushroom Magic Ebook: https://drive.google.com/file/d/19wY94Rdk64-Q9QR5M-HbQp4XP2HjB5Ov/view?usp=sharing

Join panelists Robert Kushner, MD, Jamy Ard, MD, and Jaime Almandoz, MD, to learn about BMI as a measure of excess adiposity, exploring both its strengths and limitations. Speakers: - Bob Kushner, MD - Jamy Ard, MD, FTOS - Jaime Almandoz, MD, MBA, MRCPI, FTOS This podcast is sponsored by Novo Nordisk and is intended for clinicians. Novo Nordisk is a registered trademark of Novo Nordisk A/S. All other trademarks, registered or unregistered, are the property of their respective owners. © 2025 Novo Nordisk All rights reserved. US24OB00077 June 2025

Welcome (back) to the Opioidology podcast series! Next up to bat, ‘Opioid Selection”. What's YOUR “Go To Opioid”??? No really, pick a given patient scenario, as respectively there's many, and what is your “Go To Opioid” when a prescription opioid is warranted??? Pain Guy posed this question on LinkedIn over a year ago, and society failed (as in succumbed to the Opioidphobia culture). So join us in this episode to take a methodical journey distinguishing prescription opioids to once and for (almost) all, be able to have our ducks in a row for opioid selection. Listen in to this Pain Pod episode for an unbiased, in your face, here's how it is approach to explaining opioid selection (beyond the “To Opioid or Not to Opioid” debate). Come one, come all, to the Pain Pod!!! Pain Guy • www.painguy.us

In part two of this three part series we bring you exclusive interviews from the Outcomes booth, recorded on the show floor at ThoughtSpot 2025. Our guests are: Kris Rhea with Pharmacy Market Place Outcomes Director of Product Management, Matt Kiethanom Bonnie Bond with Sykes and Company Accounting Vice President of Product Management at Outcomes, Dr. Heidi Polek and Kunal Vyas, CEO of RxMile CEO of the Alliance for Pharmacy Compounding, Scott Brunner Dr. Mark Amoo with Outcomes This episode is sponsored by Outcomes.

Multi-store owners: Are running payroll through all of your locations? This episode is a must listen... In this episode of Master the Margin, Scotty Sykes, CPA, CFP® and Kathy Blanchard, Senior Pharmacy Accountant, dive into the nuances of common paymaster status and why it's often misunderstood in multi-store pharmacy operations. They break down: - What a common paymaster is—and how it (theoretically) benefits employers - Why most multi-store pharmacy owners don't qualify, despite good intentions - The payroll risks of misclassifying employees across entities - The role of controlled group rules in IRS compliance - How common ownership impacts payroll, 401(k)s, benefits, and more Check out the full episode with bonus insights: https://masterthemargin.substack.com/ Schedule an Rx Assessment: https://www.sykes-cpa.com/rx-assessment-service/ More resources about this topic: Podcast - One Big, Beautiful Bill: What the New Tax Proposal Means for Pharmacies: https://www.youtube.com/watch?v=99jnN08jGUo Podcast - The Multi Store Owners Guide to Selling Your Pharmacy: https://www.youtube.com/watch?v=smmNR_SFOwg

AI & Tech in Pharmacy & the Health Podcast Summit | TWIRx This week on TWIRx, we dive into how technology, artificial intelligence, and innovative media are shaping the future of pharmacy. From specialty pharmacy operations to digital health engagement and independent pharmacy innovation, our guests bring timely insights you won't want to miss. TWIRx News FIP calls on authorities to ‘think humanity, think pharmacy https://ajp.com.au/news/fip-calls-on-authorities-to-think-humanity-think-pharmacy/ Iowa pharmacists are in demand as they try to fill healthcare provider gap https://www.radioiowa.com/2025/08/20/iowa-pharmacists-are-in-demand-as-they-try-to-fill-healthcare-provider-gap/ Nuvem Continues to Expand Leadership Team to Accelerate Pharmacy Service Model for Community Health Providers https://www.businesswire.com/news/home/20250820045021/en/Nuvem-Continues-to-Expand-Leadership-Team-to-Accelerate-Pharmacy-Service-Model-for-Community-Health-Providers Featured Guest: Shaun Jensen, CEO of JB Consulting Topic: How Will Tech & AI Advance Specialty Pharmacy? The specialty pharmacy system is in flux—what platforms show real stability to build the future? Emerging use cases of AI in specialty pharmacy: clinical decision support, adherence optimization, and patient engagement. The role of AI in specialty trade relations and research, driving efficiency and better outcomes for providers, manufacturers, and patients. Daniel Couchman Kendall, CEO of Mission Based Media Topic: Announcing the Health Podcast Summit Introducing the Health Podcast Summit — the first global event dedicated exclusively to the intersection of health and podcasting. October 1–2, 2025 | Virtual Event | Free Registration at HealthPodcastSummit.com Learn evidence-based, human-centered frameworks for creating and growing health podcasts. Hear from industry leaders worldwide transforming patient engagement, professional education, and health outcomes through podcasting. On-demand replays available for registered attendees. Ketan Mehta, CEO of PrimeRx Topic: PrimeRx User Conference 2025 – XPLORE October 10–11, 2025 | The Westin Jersey City Newport Xplore by PrimeRx — an exclusive user conference designed for independent pharmacy professionals, healthcare innovators, and industry leaders. Explore pharmacy management strategies, technology advancements, and digital healthcare solutions that will shape the future of independent pharmacy. A chance to connect with peers, learn from experts, and prepare for the evolving pharmacy landscape.

In part one of this three part series we bring you exclusive interviews from the Outcomes booth, recorded on the show floor at ThoughtSpot 2025. Our guests are: One of 2024's most Influential People in Pharmacy Dr. Jay Phipps, the Pharmacy Gladiator VP of Pharmacy Insights at Outcomes, Jonathan Grice Vice President of Retail Pharmacy at Outcomes, Mark Nelson Vice President of Product Management at Outcomes, Dr. Heidi Polek This episode is sponsored by Outcomes.

In this episode of FrameworkFocus, we explore how the long-term care (LTC) market has evolved from the pre-pandemic boom through COVID-19's sharp disruption to today's near-recovery. Jason Yablinsky, CFO at SoftWriters, unpacks how shifting interest rates, housing liquidity, and the coming wave of Baby Boomer demand are reshaping the industry's trajectory. Tune in to learn why today's financial constraints may soon become tomorrow's catalysts for growth.

I know I say this every time, but this episode is truly special as I interview a fellow herbalist about her story of creating a skincare line that's built on compassion for people and the planet. Aviva Tilson is the founder of Apis Apotheca, which she began 8 years ago when combining her experience with organic farming, herbalism, and desire to resolve lifelong skin issues. She specializes in sensitive, eczema and acne prone skin and continues to delve into the complexity of managing skin issues in the context of autoimmunity. Aviva's products are poems that arose from the inspiration of her garden, and the desire to show an example of a heart-centered business that is full circle and has a basis in regenerative agriculture. Her line has helped thousands of people around the globe heal their skin and feel closer to nature in the process. Tune in to hear how you can support radiant beauty within and on your skin with botanicals from the garden. Connect with Aviva via: Email: contact@apisapotheca.com Website: Apis Apotheca FB: Apis Apotheca IG: @apis.apotheca.farm Linked In: Apis Apotheca HERMES free one time shipping code